Mollet, A., T. A. Lutz, S. Meier, T. Riediger, P. A. Rushing, and E. Scharrer. Histamine H1 receptors mediate the anorectic action of the pancreatic hormone amylin. Am J Physiol Regulatory Integrative Comp Physiol 281: R1442-R1448, 2001.-We investigated the role of histamine H1 receptors in mediating the anorectic effect of intraperitoneally injected amylin (5 and 20 g/kg), the amylin agonist salmon calcitonin (sCT; 10 g/kg), leptin (1.3 mg/kg), and cholecystokinin (CCK; 20 g/kg). The experiments were performed with mice lacking functional H1 receptors (H1Rko) and wild-type (WT) controls. The mice were also injected with the H3 antagonist thioperamide (20 mg/kg), which reduces feeding by enhancing the release of endogenous histamine through presynaptic H3 receptors. The feeding-suppressive effect of thioperamide was abolished in H 1Rko mice. The anorectic effects of amylin and sCT were significantly reduced in 12-h food-deprived H1Rko mice compared with WT mice [1-h food intake: WT-NaCl 0.51 Ϯ 0.05 g vs. WT-amylin (5 g/kg) 0.30 Ϯ 0.06 g (P Ͻ 0.01); H1Rko-NaCl 0.45 Ϯ 0.05 g vs. H1Rko-amylin 0.40 Ϯ 0.04 g; WT-NaCl 0.40 Ϯ 0.09 g vs. WT-sCT (10 g/kg) 0.14 Ϯ 0.10 g (P Ͻ 0.05); H1Rko-NaCl 0.44 Ϯ 0.08 g vs. H 1Rko-sCT 0.50 Ϯ 0.06 g]. The anorectic effect of leptin was absent in ad libitum-fed H1Rko mice, whereas CCK equally reduced feeding in WT and H1Rko animals. This suggests that the histaminergic system is involved in mediating the anorectic effects of peripheral amylin and sCT via histamine H 1 receptors. The same applies to leptin but not to CCK. H 1Rko mice showed significantly increased body weight gain compared with WT mice, supporting the role of endogenous histamine in the regulation of feeding and body weight. food intake; histamine H 1 receptor knockout mice; thioperamide; salmon calcitonin; leptin; cholecystokinin AMYLIN, A 37-AMINO ACID POLYPEPTIDE that is secreted from pancreatic ␤-cells in response to food intake, has been shown to suppress feeding in rats and mice mainly by decreasing meal size (9, 12, 26) . Its satiating action is specific, since amylin does not induce a conditioned taste aversion (3, 12) . Peripheral amylin has a central site of action (8) (9) (10) 20) , and the area postrema (AP) of the hindbrain plays the predominant role in mediating the inhibitory effect of amylin on feeding (13). The anorectic effect of amylin is markedly attenuated in AP-lesioned rats (13) and is mediated by a direct activation of amylin-sensitive neurons in the AP (23, 25) .
anorectic effect of amylin is markedly attenuated in AP-lesioned rats (13) and is mediated by a direct activation of amylin-sensitive neurons in the AP (23, 25) .
Although the primary site of action for the satiating effect of peripheral amylin is clear, knowledge about the neurotransmitters and signaling pathways that are involved in mediating amylin's satiating effect in the central nervous system (CNS) is limited. Previous studies have shown that amylin's satiating effect is partially mediated by the central dopaminergic, but not serotoninergic (11) , system because blockade of dopamine D 2 receptors attenuated amylin's anorectic effect (14) . Furthermore, because injection of the H 3 agonists imetit and R-␣-methylhistamine, which block the release of endogenous histamine via presynaptic histamine H 3 receptors, reduced amylin's inhibitory effect on feeding, the histaminergic system also seems to play an important role in mediating amylin's satiating effect (11) .
Because within the CNS, histamine's inhibitory effect on feeding mainly seems to involve histamine H 1 receptors (17, 27, 28) , the aim of the present study was to investigate whether histamine mediates amylin's satiating effect via this receptor subtype. Histamine H 1 receptors have also been found in the AP/nucleus of the solitary tract (AP/NTS) region, which is involved in mediating the anorectic effect of amylin (13) , and in hypothalamic areas (27, 28) . To investigate the importance of histamine H 1 receptors in the signaling transmission of the anorectic effect of amylin, we treated histamine H 1 receptor knockout (H 1 Rko) mice with amylin and compared the anorectic effect in these mice to that in respective wild-type (WT) controls. We also tested the effect of salmon calcitonin (sCT) on food intake in these animals because sCT has been shown to reduce food intake via amylin binding sites (15) . To confirm the lack of H 1 receptors in the H 1 Rko mice, they were first injected with thioperamide, an H 3 receptor antagonist that decreases food intake by enhancing the release of endogenous histamine (16, 27) . Leptin, the ob gene product that is secreted from white adipose tissue and is involved in the regulation of food intake and body weight by acting on hypothalamic arcuate nucleus neurons (2, 31) , was used as a positive control because its anorectic effect has been reported to be absent in H 1 Rko mice (18) . Cholecystokinin (CCK) was also included in the study because the anorectic effect of CCK does not seem to depend on the histaminergic system (33) .
MATERIALS AND METHODS

Animals and Housing Conditions
The experiments were performed with knockout mice lacking functional histamine H1 receptors (H1Rko; strain C57BL) and respective WT controls (strain C57BL). The H1Rko mice were generated by homologous recombination (7) and appear phenotypically normal but show increased ambulation during the light period, decreased locomotor activity in the dark period, and reduced exploratory behavior in a new environment (7) . [ 3 H]pyrilamine and doxepin binding studies were used to verify the lack of H1 receptors (7).
Adult male H1Rko and WT mice, respectively, were used. The average age was ϳ3.5 mo when they were used for the first time in the feeding experiments. The animals were housed in standard wire cages (24 ϫ 25 ϫ 18 cm) at a room temperature of 21 Ϯ 1°C and with an artificial inversed 12:12-h light-dark cycle (lights on at 2100). The mice were adapted to the housing conditions for at least 3-4 wk before the experiments. Mice had ad libitum access to water and food (powdered medium-fat diet containing 13% protein, 46% corn starch, and 18% fat, with an energy density of 16.5 kJ/g; Kliba Mü hlen, Kaiseraugst, Switzerland) except during food deprivation just before the experiments (see below). Body weight was registered at weekly intervals.
Drugs and Experimental Design
Rat amylin, sCT, and CCK octapeptide (CCK-8) were obtained from Peninsula Laboratories (Belmont, CA). Mouse recombinant leptin and the H 3 antagonist thioperamide were obtained from RBI Products/Sigma (St. Louis, MO). All peptides were freshly dissolved in 0.9% NaCl just before the experiments. The H3 antagonist thioperamide was dissolved in sterile 0.5% sodium carboxymethylcellulose (CMC) solution. Amylin was injected at doses of 5 and 20 g/kg and the amylin receptor agonist sCT at doses of 1 and 10 g/kg. Leptin (1.3 mg/kg) was used as a positive control (18) . CCK (20 g/kg) was included in the study because its anorectic effect is reported not to depend on the histaminergic system (33) . To confirm the lack of functional histamine H 1 receptors, mice were also injected with thioperamide (20 mg/kg), a selective H3 receptor antagonist (1) that, by enhancing the release of endogenous histamine, has been shown to reduce food intake in rats (16, 27) .
For each experiment, H1Rko and WT mice were randomly divided into two groups, each with similar body weight. The order of treatment was randomized. When a crossover design was used (see below), at least 5 days were allowed for recovery between tests.
All solutions were injected intraperitoneally with an injection volume of 10 ml/kg. Injection of the same volume of the appropriate solvent served as control. Food was presented just after the injections. All experiments were performed at dark onset (0900). Food intake was assessed by measuring the weight of the food containers (Ϯ0.1 g) after correcting for food spillage and removing feces and urine. To prevent disturbance of the mice by light during the dark period, the measurement was performed under red light. Experiment 1. H 1Rko (n ϭ 15; 30.3 Ϯ 0.6 g) and WT mice (n ϭ 16; 27.8 Ϯ 0.5 g) were food deprived for 12 h during the light period (2100-0900). Thioperamide (20 mg/kg) or vehicle (0.5% sodium-CMC solution) were injected at dark onset (0900). The experiment was performed using a crossover design so that each animal served as its own control.
Experiment 2. For amylin at 5 g/kg, WT mice had an average body weight of 28.2 Ϯ 0.5 g (n ϭ 16), and H 1Rko mice had an average body weight of 29.8 Ϯ 0.8 g (n ϭ 15). For amylin at 20 g/kg, WT mice had an average body weight of 26.8 Ϯ 0.6 g (n ϭ 16), and H1Rko mice had an average body weight of 29.2 Ϯ 0.7 g (n ϭ 16). The animals were food deprived for 12 h during the light phase (2100-0900). Amylin (5 or 20 g/kg) or vehicle was injected intraperitoneally immediately before dark onset (0900). Each experiment was performed using a crossover design.
Experiment 3. For sCT at 10 g/kg, WT mice had an average body weight of 26.6 Ϯ 0.4 g (n ϭ 16), and H 1Rko mice had an average body weight of 28.1 Ϯ 0.6 g (n ϭ 15). For sCT at 1 g/kg, WT mice had an average body weight of 30.8 Ϯ 0.8 g (n ϭ 15), and H1Rko mice had an average body weight of 34.1 Ϯ 0.6 g (n ϭ 16). WT and H1Rko mice were injected intraperitoneally with sCT (1 or 10 g/kg) or vehicle immediately before dark onset (0900) after 12-h food deprivation.
Experiment 4. The experimental procedure was similar to that in the study by Morimoto et al. (18) . Ad libitum-fed WT (n ϭ 16; 27.7 Ϯ 0.4 g) and H 1Rko mice (n ϭ 15; 29.6 Ϯ 0.6 g) received an intraperitoneal injection of leptin at a dose of 1.3 mg/kg or vehicle at dark onset (0900). The experiment was performed using a crossover design.
Experiment 5. Twelve-hour food-deprived H 1Rko (n ϭ 16; 31.1 Ϯ 0.6 g) and WT mice (n ϭ 16; 28.7 Ϯ 0.8 g) were injected with CCK-8 (20 g/kg) or vehicle at dark onset (0900).
Statistics
Results are presented as means Ϯ SE. The treatment groups were compared using one-way or, when a crossover design was used, repeated-measures ANOVA with the Student-Newman-Keuls post hoc test or paired Student's t-test. The influence of the absence of functional histamine H 1 receptors in the H1Rko mice on the effects of the tested substances on food intake was investigated by two-factor ANOVA. Body weight, which was assessed at weekly intervals, was compared using the unpaired Student's t-test.
In all cases, P Ͻ 0.05 was considered significant.
RESULTS
Experiment 1
Thioperamide (20 mg/kg) significantly reduced 1-h cumulative food intake in WT mice (paired Student's t-test) by ϳ40% [food intake 1 h after injection: WTvehicle (n ϭ 16) 0.49 Ϯ 0.05 g vs. WT-thioperamide (n ϭ 15) 0.29 Ϯ 0.07 g; P Ͻ 0.05]. In H 1 Rko mice, thioperamide did not reduce feeding [food intake 1 h after injection: H 1 Rko-vehicle (n ϭ 15) 0.36 Ϯ 0.04 g vs. H 1 Rko-thioperamide (n ϭ 15) 0.43 Ϯ 0.06 g]. Because thioperamide's anorectic effect was completely abolished in the H 1 Rko mice (2-factor ANOVA: 1 h, P Ͻ 0.05), this experiment confirms the ablation of functional H 1 receptors in these animals.
Experiment 2
In experiment 2, amylin was injected at 5 or 20 g/kg.
In WT mice, amylin (5 g/kg) significantly (paired Student's t-test) reduced cumulative food intake throughout the 4-h observation period by ϳ20-40%. Amylin's anorectic effect was completely abolished in H 1 Rko mice (Fig. 1A ) (2-factor ANOVA: 4 h, P Ͻ 0.05).
At a dose of 20 g/kg, amylin significantly (repeatedmeasures ANOVA) reduced food intake throughout the 4-h observation period in WT mice. In H 1 Rko mice, amylin only slightly reduced feeding, without reaching the level of significance (Fig. 1B) .
Experiment 3
In experiment 3, sCT was injected at 1 or 10 g/kg. sCT (10 g/kg) significantly (1-way ANOVA) reduced feeding in WT mice by ϳ40-65% but had no effect on cumulative food intake in H 1 Rko mice ( Fig. 2A ) (2-factor ANOVA, interaction between the lack of H 1 receptors and the effect of treatment: 1 h, P Ͻ 0.05; 2 h, P Ͻ 0.05; 4 h, P Ͻ 0.05; and 8 h, P Ͻ 0.05).
The experiment was also performed with chow-fed mice at a dose of 1 g/kg sCT. Under these conditions, sCT significantly (1-way ANOVA) reduced cumulative food intake in WT mice by ϳ20-55% but not in H 1 Rko mice (Fig. 2B ) (2-factor ANOVA, interaction between the lack of H 1 receptors and the effect of treatment: 1 h, P Ͻ 0.05; 2 h, P Ͻ 0.01; 4 h, P Ͻ 0.01; and 8 h, P Ͻ 0.05).
Experiment 4
Leptin (1.3 mg/kg) significantly (paired Student's t-test) reduced cumulative food intake in WT mice by ϳ10-30%, whereas in H 1 Rko mice, its anorectic effect was completely abolished (Fig. 3 ) (2-factor ANOVA: 6 h, P Ͻ 0.05; 12 h, P ϭ 0.06). Fig. 2 . Influence of salmon calcitonin (sCT) at 10 g/kg (A) or 1 g/kg (B) injected intraperitoneally at dark onset on cumulative food intake in 12-h food-deprived H1Rko and WT mice compared with saline controls. Significant difference between groups: * P Ͻ 0.05, ** P Ͻ 0.01, and *** P Ͻ 0.001, by 1-way ANOVA with the Student-Newman-Keuls post hoc test. sCT at 10 g/kg: WT-NaCl and WT-sCT, n ϭ 8; H1Rko-NaCl, n ϭ 8; H1Rko-sCT, n ϭ 7. sCT at 1 g/kg:
WT-NaCl and WT-sCT, n ϭ 7; H1Rko-NaCl and H1Rko-sCT, n ϭ 8. WT-NaCl and WT-amylin, n ϭ 16; H1Rko-NaCl and H1Rko-amylin, n ϭ 15; paired Student's t-test. Amylin at 20 g/kg: for all groups, n ϭ 16; repeated measures ANOVA with the Student-NewmanKeuls post hoc test.
Experiment 5
In experiment 5, CCK-8 was injected at 20 g/kg. Cumulative food intake was significantly (1-way ANOVA) reduced by CCK-8 throughout the 2-h observation period in both WT and H 1 Rko mice (Fig. 4) . The two-factor ANOVA showed that the absence of the histamine H 1 receptor in H 1 Rko mice did not influence the anorectic effect of CCK-8. In another experiment, CCK-8 was used at a dose of 5 g/kg. In this case, CCK-8 tended to reduce feeding in WT and H 1 Rko mice, but the effects were not significant [e.g., food intake 1 h after injection (body weight of: WT 27.7 Ϯ 0.6 g, n ϭ 16; H 1 Rko 28.5 Ϯ 0.7 g, n ϭ 16): WT-NaCl 0.48 Ϯ 0.04 g vs. WT-CCK 0.38 Ϯ 0.08 g; H 1 Rko-NaCl 0.52 Ϯ 0.05 g vs. H 1 Rko-CCK 0.38 Ϯ 0.05 g].
All experiments (except with CCK-8) were repeated using another group of H 1 Rko and WT mice. In all cases, the outcome was as described before, i.e., the anorectic effects of thioperamide, amylin, sCT, and leptin, which were significant in WT mice, were abolished in H 1 Rko animals (results not shown).
We observed a significantly increased body weight gain in H 1 Rko mice compared with WT animals (Fig.  5) . In H 1 Rko mice, basal food intake tended to be higher by ϳ5% than in WT control mice, but this effect was not significant (data not shown).
DISCUSSION
In this study, we have shown that functional histamine H 1 receptors are essential for the anorectic effects of intraperitoneally administered amylin and sCT. In contrast to WT animals, in which amylin markedly reduced feeding, the anorectic action of amylin was absent in H 1 Rko mice when a dose of 5 g/kg was used. At the higher amylin dose (20 g/kg), only a slight nonsignificant reduction in feeding was observed in H 1 Rko mice. Interestingly, the inhibitory effect of sCT on feeding was also completely abolished in H 1 Rko mice at both doses of sCT (1 and 10 g/kg). sCT is structurally and functionally related to amylin (5) and seems to reduce feeding by interaction with amylin receptors (15) . In previous studies, a stronger and prolonged effect of sCT compared with amylin was observed (15) . This can be explained by the irreversible binding of sCT to amylin receptors (21) , causing a persistent neuronal activation (24) .
To verify the ablation of histamine H 1 receptors in the H 1 Rko mice, we injected these mice with the H 3 antagonist thioperamide, which reduces food intake in rats (16, 27) by enhancing the synthesis and release of Fig. 3 . Influence of leptin (1.3 mg/kg) injected intraperitoneally at dark onset on cumulative food intake in nondeprived H1Rko and WT mice compared with saline controls. Significant difference between groups: * P Ͻ 0.05, ** P Ͻ 0.01, and *** P Ͻ 0.001. WT-NaCl and WT-leptin, n ϭ 16; H1Rko-NaCl and H1Rko-leptin, n ϭ 15; paired Student's t-test. endogenous histamine (1) . It has been shown that histamine reduces feeding mainly via histamine H 1 receptors (17, 28) . The lack of an anorectic effect of thioperamide in H 1 Rko mice compared with WT animals confirms the absence of functional histamine H 1 receptors in H 1 Rko mice.
The findings of the present experiments complement our previous study (11) demonstrating a mediation of amylin's anorectic effect by the histaminergic system. The pretreatment with the H 3 receptor agonists imetit and R-␣-methylhistamine, which are able to penetrate the blood-brain barrier and block the release of endogenous histamine via presynaptic histamine H 3 receptors, reduced amylin's inhibitory effect on feeding in rats (11) . We now show that histamine mediates amylin's satiating effect through H 1 receptors.
Hypothalamic histamine is well known to be involved in the regulation of food intake and body weight (16, 17, (27) (28) (29) . Increased concentrations of central histamine are able to reduce feeding via histamine H 1 receptors (17, 28) , whereas a blockade of central histamine H 1 receptors (28) increases food intake. Additional studies showed that the H 1 receptors in the ventromedial (VMH) and paraventricular hypothalamic nuclei, which are the areas richest in hypothalamic histamine and H 1 receptors (29, 30), play the major role in this regard (29) . We therefore conclude that the amylin-induced activation of AP neurons that underlies the anorectic effect of peripheral amylin (13, 23, 25) directly or indirectly leads to an increase in hypothalamic histamine release to bring about amylin's effect by acting on hypothalamic histamine H 1 receptors. This main conclusion of our present study is corroborated by preliminary findings that an infusion of the H 1 receptor antagonist chlorpheniramine into the VMH blocked the anorectic effect of peripheral amylin in rats (unpublished data).
In previous studies, we showed that the dopaminergic system is also involved in mediating amylin's satiating effect because blockade of D 2 receptors attenuates amylin's action in rats (14) . In another study, a high density of dopamine D 2 receptors has been detected in the AP/NTS region (22) . In analogy to a blockade of the anorectic effect of amylin by H 1 antagonists into the VMH, we recently demonstrated that an infusion of the dopamine D 2 antagonist raclopride directly into the AP/NTS region also attenuates the amylin-induced reduction of feeding (unpublished observations). We therefore propose that at least a dopaminergic system in the brain stem and a histaminergic hypothalamic mechanism (e.g., in the VMH) are involved in the ascending signaling pathway mediating the anorectic effect of amylin.
Because activation of presynaptic H 3 receptors, which attenuates amylin's satiating effect (11) , not only reduces the release of histamine but, via receptors on nonhistaminergic neurons, also the release of dopamine (4), it could theoretically be possible that the attenuation of amylin's anorectic effect by histamine H 3 agonists (11) was due to an inhibition of dopamine rather than histamine release. However, we showed in the present study that amylin's anorectic effect was markedly reduced in H 1 Rko mice. It is therefore unlikely that the attenuating effect of H 3 agonists on amylin's satiating action (11) is due to an inhibition of dopamine release. Instead of a direct interaction between the dopaminergic and the histaminergic systems, we suggest the model presented above with dopamine in the AP/NTS region and histamine in the VMH as sequential mediators of amylin's anorectic effect.
In our study, we observed an increased body weight gain in H 1 Rko mice compared with the WT control animals. Higher body weight appeared to be associated with an increased fat pad mass (unpublished observations). This was paralleled by an increase in basal food intake in the H 1 Rko mice, although the latter effect was not significant. Over time, however, the higher food intake probably contributes to the observed differences in body weight (and fat mass). These findings underline the overall importance of the histaminergic system and H 1 receptors in the regulation of food intake and body weight (29) .
Our results support previous findings that the histaminergic system plays an important role in the feeding-suppressive effect of intraperitoneally administered leptin. Morimoto et al. (18, 19) and Yoshimatsu et al. (35) have shown that the central histaminergic system is involved in leptin's anorectic effect because the specific histidine decarboxylase inhibitor ␣-fluoromethylhistidine abolished the anorectic effect of leptin in mice and because leptin's inhibitory effect on feeding was absent in H 1 Rko mice (18, 35) . The latter effect was confirmed in the present study. It is possible that leptin is able to reduce feeding in H 1 Rko mice when administered at higher doses, indicating that other neurotransmitters are also involved in leptin action (2, 34) . A similar conclusion can be drawn for amylin, which, at the high dose used (20 g/kg), appeared to produce some weak, albeit nonsignificant, reduction in feeding in the H 1 Rko mice.
The findings of this and other studies (18, 35 ) that the anorectic effects of both amylin and leptin are mediated via histamine H 1 receptors raise the question as to whether the central nervous signaling pathways for amylin, which acts through activation of AP neurons (13, 23, 25) , and leptin, which acts primarily via arcuate hypothalamic nucleus neurons (31, 34), converge via the histaminergic system in the VMH.
We also injected the mice with CCK, which acts as an important satiating peptide (6) . We have shown that CCK reduces food intake with equal potency in both H 1 Rko and WT mice compared with saline controls. Consequently, histamine H 1 receptors are not necessary in the transmission of the anorectic action of CCK. These data not only confirm previous studies demonstrating that the anorectic effect of CCK does not depend on the histaminergic but rather the serotoninergic system (33) , but also underline the specificity of the observed effects in our present investigations.
In conclusion, we have shown that the histaminergic system is involved in mediating the anorectic effects of amylin, sCT, and leptin but not CCK through histamine H 1 receptors in mice. Furthermore, H 1 Rko mice showed significantly increased body weight gain compared with the WT animals, supporting the role of endogenous histamine in the regulation of food intake and body weight.
Perspectives
The results of this and other studies have shown that histamine via H 1 receptors and dopamine via D 2 receptors (14) are involved in mediating the anorectic effect of amylin. As discussed, it is not clear where in the CNS these neurotransmitter systems that are involved in amylin's satiating effect are located. Some evidence indicates, however, that the amylin-induced activation of AP neurons, which seems to underlie the anorectic action of peripheral amylin (13, 23, 25) , leads to a release of dopamine that acts locally on D 2 receptors of other neurons that then directly or indirectly influence hypothalamic histamine release to bring about amylin's effect by acting on hypothalamic histamine H 1 receptors, e.g., in the VMH.
The findings that the anorectic effects of both amylin and leptin are partly mediated via histamine H 1 receptors (18, 35) raise the question as to whether the central nervous signaling pathways for amylin, which acts on AP neurons (13, 23, 25) , and leptin, which acts primarily via arcuate hypothalamic nucleus neurons (31, 34) , converge via the histaminergic system in the VMH. It also remains to be investigated whether this convergence could be the neuroanatomical basis for a modulation of the anorectic action of the satiating peptide amylin, a possible signal for direct control of meal size (32) , by leptin, a signal for indirect control of meal size (32) . Future studies will have to address these open questions by a combination of feeding studies and other experimental techniques to clarify the ascending signaling pathway for the anorectic action of amylin and its interaction with other anorectic agents. It also remains to be investigated whether other neurotransmitters and/or neuropeptides in the CNS feeding centers are affected by amylin.
